Impact of Obesity and Ageing on the Expression of Key Mediators of SARS-CoV-2 Infection in Human Adipose Tissue
Authors:
- Maria SalazarMaria Salazar
- Mariana FerreiraMFMariana Ferreira
- Sandra Marisa OliveiraSOSandra Marisa Oliveira
- Francisca SaraivaFSFrancisca Saraiva
- Carlos PinhoCPCarlos Pinho
- Mariana JarnaloMJMariana Jarnalo
- Inês Correia-SáICInês Correia-Sá
- Inês Falcão-PiresIFInês Falcão-Pires
- Adelino Leite-MoreiraALAdelino Leite-Moreira
- Delminda NevesDNDelminda Neves
- Henrique AlmeidaHenrique Almeida
- Adriana R. RodriguesARAdriana R. Rodrigues
Open Access
- 29 July 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (15) , 7313
Abstract
Increased body mass index (BMI) and age are associated with COVID-19 severity. SARS-CoV-2 infection occurs through ACE2 binding, with TMPRSS2, ADAM17, and NRP1 facilitating this process. This study describes how adipose tissue (AT) location, BMI, age, and obesity affect these proteins’ expression. AT was collected from subcutaneous (abdominal superficial [AS], abdominal deep [AD], thigh [T]) and visceral (epiploon [E]) areas from middle-aged women without obesity (BMI 23.9 kg/m2, age 48.3 years). Subcutaneous AT was also obtained from middle-aged women with previous obesity (BMI 24.8 kg/m2, previously 41.7 kg/m2, age 46.9 years), older women with obesity (BMI 32.3 kg/m2, age 70.8 years), and older women without obesity (BMI 23.7 kg/m2, age 70.6 years). ACE2, TMPRSS2, ADAM17, and NRP1 expression was evaluated by qPCR and Western blotting. All proteins were more expressed in visceral AT. ACE2, TMPRSS2, and NRP1 positively correlated with BMI in AS and/or E, while NRP1 correlated with age in T. In subcutaneous AT, ACE2 and NRP1 were more influenced by obesity while TMPRSS2 was more age-dependent. In women with previous obesity, ACE2 and NRP1 levels decreased, while TMPRSS2 and ADAM17 remained unchanged. These findings highlight the differential influence of visceral AT, obesity, and age on the expression of SARS-CoV-2 cell entry mediators, potentially contributing to COVID-19 severity.Keywords
Funding Information
- European Union and the Portuguese Foundation for Science and Technology (FCT) (UIDB/00051/2020, UIDP/00051/2020)
- FCT–Portuguese Foundation for Science and Technology (UIDB/00051/2020, UIDP/00051/2020)
This publication has 76 references indexed in Scilit:
- Etiology of prostate cancer with the TMPRSS2:ERG fusion: A systematic review of risk factorsInternational Journal of Cancer, 2024
- The interplay of aging, adipose tissue, and COVID-19: a potent alliance with implications for healthGeroScience, 2024
- Bidirectional causal associations between type 2 diabetes and COVID‐19Journal of Medical Virology, 2022
- SARS-CoV-2 cell entry beyond the ACE2 receptorMolecular Biology Reports, 2022
- Roux-en-Y Gastric Bypass Downregulates Angiotensin-Converting Enzyme 2 (ACE2) Gene Expression in Subcutaneous White Adipose Tissue: A Putative Protective Mechanism Against Severe COVID-19Obesity Surgery, 2021
- Serum levels of ACE2 are higher in patients with obesity and diabetesObesity Science & Practice, 2020
- Obesity as a Potential Predictor of Disease Severity in Young COVID‐19 Patients: A Retrospective StudyObesity, 2020
- Obesity predisposes to the risk of higher mortality in young COVID‐19 patientsJournal of Medical Virology, 2020
- Obesity and its Implications for COVID‐19 MortalityObesity, 2020
- miRNA‐124‐3p/neuropilin‐1(NRP‐1) axis plays an important role in mediating glioblastoma growth and angiogenesisInternational Journal of Cancer, 2018